Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Immunogenicity and Safety of DPT/HB/Hib (Bio Farma) Vaccine Compared to DTP/HB (Bio Farma) Vaccine Given Simultaneously With Hib (Registered) Vaccine in Indonesian Infants

NCT01986322 is registered in ClinicalTrials.gov with PT Bio Farma as lead sponsor.

NCT NCT01986322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01986322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Immunogenicity and Safety of DPT/HB/Hib (Bio Farma) Vaccine Compared to DTP/HB (Bio Farma) Vaccine Given Simultaneously With Hib (Registered) Vaccine in Indonesian Infants
Lead sponsor
PT Bio Farma
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2011
Completion date
January 31, 2012
Enrollment
220 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

healthy